The latest closing stock price for Avalo Therapeutics as of April 09, 2025 is 5.10.
An investor who bought $1,000 worth of Avalo Therapeutics stock at the IPO in 2015 would have $-1,000 today, roughly -1 times their original investment - a -57.60% compound annual growth rate over 9 years.
The all-time high Avalo Therapeutics stock closing price was 20793.60 on February 27, 2019.
The Avalo Therapeutics 52-week high stock price is 18.79, which is 268.4% above the current share price.
The Avalo Therapeutics 52-week low stock price is 5.00, which is 2% below the current share price.
The average Avalo Therapeutics stock price for the last 52 weeks is 10.13.
An investor who bought $1,000 worth of Avalo Therapeutics stock at the IPO in 2015 would have $-1,000 today, roughly -1 times their original investment - a -57.60% compound annual growth rate over 9 years.
The all-time high Avalo Therapeutics stock closing price was 20793.60 on February 27, 2019.
The Avalo Therapeutics 52-week high stock price is 18.79, which is 268.4% above the current share price.
The Avalo Therapeutics 52-week low stock price is 5.00, which is 2% below the current share price.
The average Avalo Therapeutics stock price for the last 52 weeks is 10.13.